dc.contributor.author | Faisal Elsenoussi, Mohammed | |
dc.date.accessioned | 2020-09-30T07:29:38Z | |
dc.date.available | 2020-09-30T07:29:38Z | |
dc.date.issued | 2020-03-12 | |
dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/2067 | |
dc.description | Acromegaly is a hormonal disorder that results from excessive secretion of growth
hormone (GH) in the body. The pituitary, a small gland in the brain, makes GH.
Usually the excess GH comes from benign, or noncancerous tumors on the pituitary.
These benign tumors are called adenomas. (1)
Acromegaly is most often diagnosed in middle-aged adults, although symptoms can
appear at any age. If not treated, acromegaly can result in serious illness and
premature death. Acromegaly is treatable in most patients, but because of its slow and
often "sneaky" onset, it often is not diagnosed early or correctly. (2) The most serious
health consequences of acromegaly are type 2 diabetes, high blood pressure, increased
risk of cardiovascular disease, and arthritis. Patients with acromegaly are also at
increased risk of colon polyps, which may develop into colon cancer if not removed. | en_US |
dc.description.abstract | Acromegaly is a chronic debilitating disorder resulting from excessive secretion of
growth hormone and a resulting increase in the production of insulin-like growth
factor I (IGF-I). It is usually caused by somatotroph adenomas of the pituitary gland.
The goal of treatment is to reverse the effects of the hyper-secretion of growth
hormone and normalize production of IGF-I. Effective treatment ameliorates the
symptoms and signs of the disease and lowers the mortality rate. | en_US |
dc.language.iso | en | en_US |
dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title | Treatment of Acromegaly | en_US |
dc.type | Other | en_US |